Perioperative chemotherapy of oxaliplatin combined with S-1 (SOX) versus postoperative chemotherapy of SOX or oxaliplatin with capecitabine (XELOX) in locally advanced gastric adenocarcinoma with D2 gastrectomy: A randomized phase III trial (RESOLVE trial)

Publication | Open Access

DOI Full Paper Access

Citations

References

2019

Year

J. Ji, Lei Shen, Z. Li, X. Zhang, Yuting Xue, Yuquan Wang, Zheng Zhou, Jingxin Yu, L. Chen, Yue Du,

Annals of Oncology

Surgical OncologyGastrointestinal OncologyMedicinePerioperative ChemotherapyResolve TrialAdvanced Gastric AdenocarcinomaSurgeryCancer TreatmentOncologyRadiation OncologyCancer Research